In a study of the effects of aging on gene expression, researchers have found that variation in gene expression among individuals tends to increase with age. The findings, which impact our understanding of the molecular forces that govern age-related changes, are reported in the May 23rd issue of Current Biology by Mehmet Somel and colleagues at the Max Planck Institute for Evolutionary Anthropology and the University of Cambridge.
One long-standing observation concerning the physiological decline that accompanies aging is its variability--some people age better than others. However, there has thus far been little or no evidence supporting the existence of similar heterogeneity at the level of gene expression. Lack of such evidence, in turn, gives support to a "programmed aging" hypothesis and argues against the more commonly accepted "stochastic aging" model, in which random biological events play an important role.
In the new work, researchers put to the test the question of whether gene-expression heterogeneity increases with age. Using a wide range of expression data from both humans and rats, the researchers showed that levels of gene expression become more variable with age. Furthermore, they found that the tendency toward increased variation is not restricted to a specific set of genes, implying that increased heterogeneity is the outcome of random processes such as genetic mutation.
These observations corroborate the notion that aging is underpinned by stochastic events. That said, the authors of the study point out that the observed increases in expression variation are surprisingly small, leaving plenty of room for further explanations regarding the relationship between aging-related changes at the organismal level and the underlying molecular mechanisms of aging. Nevertheless, the new results show that with the increasing amounts of molecular data available to researchers, scientists will now experience improved opportunities to answer age-old questions about the nature of aging.
Source: Cell Press
Related stories:
Fountain of Youth to be found in the anthill?
Aging – we are all doing it. It is relentless and terminal. Auguries and alchemists, mendicants and magicians, philosophers and science fiction writers, researchers and plastic surgeons have employed all their various arts in the pursuits of "turning back the clock." Yet, we stand in modern times with a span of a century to our name, at most.
Biomarkers used to predict chronological and physiological age
Scientists at the Buck Institute for Age Research have identified for the first time biomarkers of aging which are highly predictive of both chronological and physiological age. Biomarkers are biochemical features that can be used to measure the progress of disease or the effects of treatment.
New research on gene sheds light on T-cell production
New research, just published by researchers from the University of Georgia, provides the first evidence that a key gene may be crucial to maintaining the production of the thymus and its disease-fighting T-cells after an animal's birth.
Type-1 diabetes not so much bad genes as good genes behaving badly
Investigators combing the genome in the hope of finding genetic variants responsible for triggering early-onset diabetes may be looking in the wrong place, new research at the Stanford University School of Medicine suggests.
Researchers uncover new links between stem cells, aging and cancer
(PhysOrg.com) -- Four genes previously implicated in the control of cancer have been shown by University of Michigan scientists to play key roles in the aging process and stem-cell regulation.
Genes that control cell death fingered in age-related hearing loss
Several genes that play a role in how our body's cells normally auto-destruct may play a role in age-related hearing loss, according to research published online in the journal
Apoptosis – a journal devoted to the topic of cell suicide, or programmed cell death.
70 years old and going strong with Down syndrome and no dementia
In the world of Down syndrome, 'Mr. C' is a rarity. A real person whose progress has been tracked for the past 16 years, at seventy, 'Mr. C' has well surpassed the average life expectancy of a person with Down syndrome, currently in the late fifties, but in the teens when 'Mr. C' was born. Further, 'Mr. C' does not exhibit clinical symptoms of Alzheimer's disease, which is almost a given for people with typical Down syndrome over 65 yeas of age.
Researchers offer first direct proof of how osteoarthritis destroys cartilage
A team of orthopaedic researchers has found definitive, genetic proof of how the most common form of arthritis destroys joint cartilage in nearly 21 million aging Americans, according to a study published online Sept. 2 in the
Journal of Bone and Mineral Research. The findings serve as an important foundation for the design of new treatments for osteoarthritis (OA), researchers said.